ID16217A - Aminoalkil dan asilaminoalkil eter, proses untuk pembuatannya, dan pemakaiannya sebagai antagonis reseptor bradykinin - Google Patents

Aminoalkil dan asilaminoalkil eter, proses untuk pembuatannya, dan pemakaiannya sebagai antagonis reseptor bradykinin

Info

Publication number
ID16217A
ID16217A IDP970758A ID970758A ID16217A ID 16217 A ID16217 A ID 16217A ID P970758 A IDP970758 A ID P970758A ID 970758 A ID970758 A ID 970758A ID 16217 A ID16217 A ID 16217A
Authority
ID
Indonesia
Prior art keywords
bradycinin
asylaminoalkil
aminoalkil
eter
processes
Prior art date
Application number
IDP970758A
Other languages
English (en)
Indonesian (id)
Inventor
Holger Dr Heitsch
Adalbert Dr Wagner
Klaus Dr Wirth
Bernward Prof Dr Scholkens
Gerhard Dr Nolken
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of ID16217A publication Critical patent/ID16217A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
IDP970758A 1996-03-13 1997-03-10 Aminoalkil dan asilaminoalkil eter, proses untuk pembuatannya, dan pemakaiannya sebagai antagonis reseptor bradykinin ID16217A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19609827A DE19609827A1 (de) 1996-03-13 1996-03-13 Aminoalkyl- und Acylaminoalkylether, Verfahren zu deren Herstellung und ihre Verwendung als Bradykinin-Rezeptorantagonisten

Publications (1)

Publication Number Publication Date
ID16217A true ID16217A (id) 1997-09-11

Family

ID=7788139

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP970758A ID16217A (id) 1996-03-13 1997-03-10 Aminoalkil dan asilaminoalkil eter, proses untuk pembuatannya, dan pemakaiannya sebagai antagonis reseptor bradykinin

Country Status (26)

Country Link
US (1) US6140341A (zh)
EP (1) EP0795547B1 (zh)
JP (1) JP4317597B2 (zh)
KR (1) KR970065521A (zh)
AR (1) AR006189A1 (zh)
AT (1) ATE192738T1 (zh)
AU (1) AU1621797A (zh)
BR (1) BR9701267A (zh)
CA (1) CA2199771A1 (zh)
CZ (1) CZ76697A3 (zh)
DE (2) DE19609827A1 (zh)
DK (1) DK0795547T3 (zh)
ES (1) ES2148858T3 (zh)
GR (1) GR3033415T3 (zh)
HR (1) HRP970138A2 (zh)
HU (1) HUP9700566A1 (zh)
ID (1) ID16217A (zh)
IL (1) IL120427A0 (zh)
NO (1) NO971136L (zh)
PL (1) PL318923A1 (zh)
PT (1) PT795547E (zh)
SI (1) SI0795547T1 (zh)
SK (1) SK32097A3 (zh)
TR (1) TR199700184A2 (zh)
TW (1) TW363891B (zh)
ZA (1) ZA972129B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6207679B1 (en) 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
JP2002505689A (ja) 1997-06-19 2002-02-19 セプレイコー インコーポレイテッド キノリン−インドール抗菌剤、それらに関する用途及び組成物
US6376670B1 (en) 1997-06-19 2002-04-23 Sepracor Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
US6103905A (en) * 1997-06-19 2000-08-15 Sepracor, Inc. Quinoline-indole antimicrobial agents, uses and compositions related thereto
EP1914236A1 (en) 2002-04-10 2008-04-23 Ortho-McNeil Pharmaceutical, Inc. Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
ITMI20021247A1 (it) * 2002-06-07 2003-12-09 Menarini Ricerche Spa Antagonisti basici non peptidici della bradichinina e loro impiego informulazioni farmaceutiche
TWI407960B (zh) 2007-03-23 2013-09-11 Jerini Ag 小分子緩激肽b2受體調節劑
AU2008319397B2 (en) 2007-11-01 2013-01-31 Acucela, Inc. Amine derivative compounds for treating ophthalmic diseases and disorders
MA50804B1 (fr) 2017-11-24 2022-05-31 Pharvaris Netherlands B V Nouveaux antagonistes des récepteurs de bradykinine b2
AR118982A1 (es) 2019-05-23 2021-11-17 Pharvaris Gmbh Antagonistas cíclicos del receptor b2 de bradiquinina
UY38707A (es) 2019-05-23 2020-12-31 Pharvaris Gmbh Nuevos antagonistas cíclicos del receptor b2 de bradiquinina
DK4203919T3 (da) 2021-08-05 2024-04-29 Pharvaris Gmbh Lipidbaseret sammensætning til oral administration af bradykinin-b2-receptorantagonister
WO2023180577A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Therapeutic uses of bradykinin b2-receptor antagonists
WO2023180575A1 (en) 2022-03-25 2023-09-28 Pharvaris Gmbh Solid composition comprising solubilised bradykinin b2-receptor antagonists
TW202345810A (zh) 2022-03-25 2023-12-01 瑞士商帕法瑞斯有限責任公司 包含緩激肽b2受體拮抗劑之固態延長釋放組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216165A (en) * 1990-10-03 1993-06-01 American Home Products Corporation N-substituted aminoquinolines as analgesic agents
US5288725A (en) * 1992-10-15 1994-02-22 Merck & Co., Inc. Pyrroloquinoline Bradykinin antagonist
AU680870B2 (en) * 1993-04-28 1997-08-14 Astellas Pharma Inc. New heterocyclic compounds
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
ATE269310T1 (de) * 1994-10-27 2004-07-15 Fujisawa Pharmaceutical Co Pyridopyrimidinone, chinoline und anellierte n- heterozyklen als bradykinin-antagonisten
FR2735128B1 (fr) * 1995-06-07 1997-07-25 Fournier Ind & Sante Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique.
FR2737892B1 (fr) * 1995-08-17 1997-10-24 Fournier Ind & Sante Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique

Also Published As

Publication number Publication date
HRP970138A2 (en) 1998-04-30
KR970065521A (ko) 1997-10-13
DE19609827A1 (de) 1997-09-18
TR199700184A2 (xx) 1997-10-21
ATE192738T1 (de) 2000-05-15
SI0795547T1 (en) 2000-10-31
HUP9700566A1 (hu) 2000-08-28
AR006189A1 (es) 1999-08-11
CA2199771A1 (en) 1997-09-13
PL318923A1 (en) 1997-09-15
BR9701267A (pt) 1999-01-12
JPH101472A (ja) 1998-01-06
NO971136L (no) 1997-09-15
IL120427A0 (en) 1997-07-13
DE59701617D1 (de) 2000-06-15
NO971136D0 (no) 1997-03-12
DK0795547T3 (da) 2000-09-18
EP0795547B1 (de) 2000-05-10
GR3033415T3 (en) 2000-09-29
AU1621797A (en) 1997-09-18
ES2148858T3 (es) 2000-10-16
PT795547E (pt) 2000-10-31
HU9700566D0 (en) 1997-04-28
CZ76697A3 (en) 1997-10-15
SK32097A3 (en) 1998-01-14
MX9701857A (es) 1997-09-30
JP4317597B2 (ja) 2009-08-19
EP0795547A1 (de) 1997-09-17
TW363891B (en) 1999-07-11
US6140341A (en) 2000-10-31
ZA972129B (en) 1997-09-15

Similar Documents

Publication Publication Date Title
ID19623A (id) Antagonis reseptor vitronektin
ID18003A (id) Antagonis muskarinik
ID16217A (id) Aminoalkil dan asilaminoalkil eter, proses untuk pembuatannya, dan pemakaiannya sebagai antagonis reseptor bradykinin
ID26007A (id) Proses karbonilasi
ID16742A (id) Antagonis reseptor endotelin
ID19253A (id) Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya
ID29461A (id) Proses desulfurisasi
ID16507A (id) Eprosartan dihidrat dan suatu proses untuk produksi dan formulasinya
GB2349952B (en) Real-time engine misfire detection method
ID23316A (id) Proses karbonilasi
ID26223A (id) Antagonis reseptor vitronektin
ID19245A (id) Antagonis reseptor vitronektin, pembuatannya dan pemakaiannya
DE69823694D1 (de) Thrombin-rezeptor antagonisten
ID23351A (id) PROSES PERSIAPAN PIRAZOLO[4,3-d]PIRIMIDIN-7ON DAN SENYAWA - ANTARANYA
ID16274A (id) Antagonis bradikinin heterosiklik pengganti-fluoroalkil dan fluoroalkoksi, proses pembuatan dan pemakaiannya
ID20274A (id) Proses untuk memproduksi diamina
ID22838A (id) Oksazolidina sebagai antagonis 5-ht2a
ID24468A (id) 2-asilaminopropanamina sebagai antagonis reseptor tachykinin
ID28811A (id) Antagonis reseptor vitronektin
ID26243A (id) Proses penyiapan butanediol, butirolakton dan tetrahidrofuran
ID27845A (id) Turunan tetrahidrokuilina sebagai antagonis glisilina
ID16751A (id) Suatu proses untuk pembuatan pentaeritol
DE69732715D1 (de) Tachykinin antagoniste
ID28625A (id) Proses untuk modifikasi pektin secara enzimatik
DE69815409D1 (de) Normalisiertes Zündaussetzererkennungsverfahren